Posted on September 29th, 2014
Mr. Roelof Rongen is the Chief Executive Officer and a Co-Founder of Matinas BioPharma.
Company OverviewMatinas BioPharma Holdings, Inc. (OTCQB: MTNB) is a development stage biopharmaceutical company, founded in 2011, with a focus on identifying and developing novel pharmaceutical products for the treatment of abnormalities in blood lipids, referred to as dyslipidemia, and the treatment of cardiovascular and metabolic diseases. Matinas is building on the extensive and proprietary research and development capabilities of its founding management team. The Matinas BioPharma team brings a cumulative multi-decade omega-3 pharmaceutical development and commercialization experience to the Company, providing a unique perspective and capability for creating the next generation of omega-3-fatty-acid-based pharmaceutical products. The newest scientific discoveries demonstrate that essential fatty acids are not just metabolic substrates or structural building blocks, but they also directly act on nuclear receptors and ar... Learn More »
Dear Readers, Recently there have been some extremely important developments relating to the introduction of new clinica...Read More »
Posted on September 22nd, 2014
At 10:29 p.m. this evening it will officially be fall in Princeton, NJ, the home of Advaxis. The formal passage of summe...Read More »
Posted on September 18th, 2014
Management is acutely aware of the depreciation in the value of our equity over the last several weeks. We have undertak...Read More »
Posted on September 16th, 2014
Over the weekend, the New York Times published a front-page article entitled; “Brain Trauma to Affect One in Three...Read More »
Posted on September 15th, 2014
It is my pleasure to introduce you to Targeted Medical Pharma (TRGM) with my first blog in a series of informative discu...Read More »
Reveal Insights About Your Company and Industry to Shareholders.
The Chairman's Blog is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. The Chairman's Blog enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. Learn More »